Drug Type Antibody |
Synonyms TRS 013, TRS013 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | CN | 19 Sep 2024 | |
Osteosarcoma | Preclinical | CN | 19 Sep 2024 | |
Soft Tissue Sarcoma | Preclinical | CN | 19 Sep 2024 | |
Triple Negative Breast Cancer | Preclinical | CN | 19 Sep 2024 |